Please provide your email address to receive an email when new articles are posted on . One expert said there are three immunological subtypes of multiple sclerosis. Another argued that MS should be ...

There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

Improvements in safety, efficacy, and specificity have raised questions around the benefits and risks of switching treatments for this type of MS, especially from fingolimod to siponimod. There are ...

The University of Virginia’s (UVA) health system has become one of the first in the country to administer a groundbreaking FDA-approved drug, Ocrevus Zunovo, to patients with progressive types of ...